pubmed-article:21497043 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0019080 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0042971 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0085862 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C1705413 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C1299583 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0332257 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C0205164 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C1608386 | lld:lifeskim |
pubmed-article:21497043 | lifeskim:mentions | umls-concept:C1549571 | lld:lifeskim |
pubmed-article:21497043 | pubmed:issue | 25 | lld:pubmed |
pubmed-article:21497043 | pubmed:dateCreated | 2011-6-17 | lld:pubmed |
pubmed-article:21497043 | pubmed:abstractText | The purpose of this study was to evaluate the prognostic value of plasma von Willebrand factor (vWF) levels and fibrin d-dimer in a large cohort of anticoagulated permanent atrial fibrillation (AF) patients. | lld:pubmed |
pubmed-article:21497043 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21497043 | pubmed:language | eng | lld:pubmed |
pubmed-article:21497043 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21497043 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:21497043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21497043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21497043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21497043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21497043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21497043 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21497043 | pubmed:month | Jun | lld:pubmed |
pubmed-article:21497043 | pubmed:issn | 1558-3597 | lld:pubmed |
pubmed-article:21497043 | pubmed:author | pubmed-author:XXX | lld:pubmed |
pubmed-article:21497043 | pubmed:author | pubmed-author:LipGregory... | lld:pubmed |
pubmed-article:21497043 | pubmed:author | pubmed-author:MarínFrancisc... | lld:pubmed |
pubmed-article:21497043 | pubmed:author | pubmed-author:RoldánVanessa... | lld:pubmed |
pubmed-article:21497043 | pubmed:author | pubmed-author:ValdésMariano... | lld:pubmed |
pubmed-article:21497043 | pubmed:author | pubmed-author:Hernández-Rom... | lld:pubmed |
pubmed-article:21497043 | pubmed:author | pubmed-author:MuiñaBegoñaB | lld:pubmed |
pubmed-article:21497043 | pubmed:author | pubmed-author:TorregrosaJos... | lld:pubmed |
pubmed-article:21497043 | pubmed:copyrightInfo | Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:21497043 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21497043 | pubmed:day | 21 | lld:pubmed |
pubmed-article:21497043 | pubmed:volume | 57 | lld:pubmed |
pubmed-article:21497043 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21497043 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21497043 | pubmed:pagination | 2496-504 | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:meshHeading | pubmed-meshheading:21497043... | lld:pubmed |
pubmed-article:21497043 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21497043 | pubmed:articleTitle | Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. | lld:pubmed |
pubmed-article:21497043 | pubmed:affiliation | Hematology and Medical Oncology Unit, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain. | lld:pubmed |
pubmed-article:21497043 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21497043 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21497043 | lld:pubmed |